David Pamies

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


26 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
2024
Promoting reusable and open methods and protocols (PRO-MaP) can improve methodological reporting in the life sciences.
Batista Leite S., Brooke M.A., Carusi A., Collings A., Deceuninck P., Dechamp J.F., Dekker B., De Ranieri E., Ganley E., Gastaldello A. et al., 2024/09. PLoS biology, 22 (9) pp. e3002835. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_068E2BAE4E8D]
Recommendations on fit-for-purpose criteria to establish quality management for microphysiological systems and for monitoring their reproducibility.
Pamies D., Ekert J., Zurich M.G., Frey O., Werner S., Piergiovanni M., Freedman B.S., Keong Teo A.K., Erfurth H., Reyes D.R. et al., 2024/05/14. Stem cell reports, 19 (5) pp. 604-617. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1C641B815478]
Novel Strategy to Assess the Neurotoxicity of Organic Solvents Such as Glycol Ethers: Protocol for Combining In Vitro and In Silico Methods With Human-Controlled Exposure Experiments.
Hopf N.B., Suter-Dick L., Huwyler J., Borgatta M., Hegg L., Pamies D., Paschoud H., Puligilla R.D., Reale E., Werner S. et al., 2024/01/18. JMIR research protocols, 13 pp. e50300. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_41A06BB224C8]
2023
 
P21-08: Building a strategy to assess the neurotoxicity of glycol ethers
Pamies D., Werner S., Puligilla R. Deepthi, Paschoud H., Hegg L., Reale E., Borgatta M., Bertoli J., Repond C., Meister I. et al., 2023/09., 57th Congress of the European Societies of Toxicology (EUROTOX 2023), 10-13 September 2023 pp. S240-S241 dans Toxicology Letters.
[DOI][serval:BIB_1E0E742B2420]
G × E interactions as a basis for toxicological uncertainty.
Suciu I., Pamies D., Peruzzo R., Wirtz P.H., Smirnova L., Pallocca G., Hauck C., Cronin MTD, Hengstler J.G., Brunner T. et al., 2023/07. Archives of toxicology, 97 (7) pp. 2035-2049. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_ED67764555FA]
 
Human brain microphysiological systems in the study of neuroinfectious disorders.
Barreras P., Pamies D., Hartung T., Pardo C.A., 2023/07. Experimental neurology, 365 p. 114409. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_48D976A6A29D]
 
Novel Strategy to Assess the Neurotoxicity of Organic Solvents Such as Glycol Ethers: Protocol for Combining In Vitro and In Silico Methods With Human-Controlled Exposure Experiments (Preprint)
Hopf Nancy B, Suter-Dick Laura, Huwyler Jörg, Borgatta Myriam, Hegg Lucie, Pamies David, Paschoud Hélène, Puligilla Ramya Deepthi, Reale Elena, Werner Sophie et al., 2023/06/26..
[DOI][serval:BIB_6E0E9D38A31B]
Digoxin Induces Human Astrocyte Reaction In Vitro.
Pamies D., Vujić T., Schvartz D., Boccard J., Repond C., Nunes C., Rudaz S., Sanchez J.C., González-Ruiz V., Zurich M.G., 2023/01. Molecular neurobiology, 60 (1) pp. 84-97. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F7961A5E222B]
Integrating distribution kinetics and toxicodynamics to assess repeat dose neurotoxicity in vitro using human BrainSpheres: a case study on amiodarone.
Nunes C., Proença S., Ambrosini G., Pamies D., Thomas A., Kramer N.I., Zurich M.G., 2023. Frontiers in pharmacology, 14 p. 1248882. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5026E918AA69]
Natural and synthetic nanovectors for cancer therapy.
Eftekhari A., Kryschi C., Pamies D., Gulec S., Ahmadian E., Janas D., Davaran S., Khalilov R., 2023. Nanotheranostics, 7 (3) pp. 236-257. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1413AD195F3E]
2022
 
Quality criteria for in vitro human pluripotent stem cell-derived models of tissue-based cells.
Pistollato F., Bal-Price A., Coecke S., Parvatam S., Pamies D., Czysz K., Hao J., Kee K., Teo AKK, Niu S. et al., 2022/09. Reproductive toxicology, 112 pp. 36-50. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2F38F7595CD3]
Human IPSC 3D brain model as a tool to study chemical-induced dopaminergic neuronal toxicity.
Pamies D., Wiersma D., Katt M.E., Zhao L., Burtscher J., Harris G., Smirnova L., Searson P.C., Hartung T., Hogberg H.T., 2022/07. Neurobiology of disease, 169 p. 105719. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_011D008B5D06]
An in vitro strategy using multiple human induced pluripotent stem cell-derived models to assess the toxicity of chemicals: A case study on paraquat.
Nunes C., Singh P., Mazidi Z., Murphy C., Bourguignon A., Wellens S., Chandrasekaran V., Ghosh S., Zana M., Pamies D. et al., 2022/06. Toxicology in vitro, 81 p. 105333. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FEAAC77037C3]
 
Probabilistic modelling of developmental neurotoxicity based on a simplified adverse outcome pathway network.
Spînu N., Cronin MTD, Lao J., Bal-Price A., Campia I., Enoch S.J., Madden J.C., Mora Lagares L., Novič M., Pamies D. et al., 2022/02. Computational toxicology, 21 p. 100206. Peer-reviewed.
[DOI][Pmid][serval:BIB_94666E954093]
 
Towards a qAOP framework for predictive toxicology - Linking data to decisions.
Paini A., Campia I., Cronin MTD, Asturiol D., Ceriani L., Exner T.E., Gao W., Gomes C., Kruisselbrink J., Martens M. et al., 2022/02. Computational toxicology, 21 p. 100195. Peer-reviewed.
[DOI][Pmid][serval:BIB_1C2EEE25D106]
 
Guidance document on Good Cell and Tissue Culture Practice 2.0 (GCCP 2.0).
Pamies D., Leist M., Coecke S., Bowe G., Allen D.G., Gstraunthaler G., Bal-Price A., Pistollato F., de Vries RBM, Hogberg H.T. et al., 2022. ALTEX, 39 pp. 30-70. Peer-reviewed.
[DOI][Pmid][serval:BIB_45A680DBFDC2]
2021
 
Human IPSC-Derived Model to Study Myelin Disruption.
Chesnut M., Paschoud H., Repond C., Smirnova L., Hartung T., Zurich M.G., Hogberg H.T., Pamies D., 2021/08/31. International journal of molecular sciences, 22 (17) p. 9473. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_45BEDBE1924C]
 
Human Oligodendrocytes and Myelin In Vitro to Evaluate Developmental Neurotoxicity.
Chesnut M., Hartung T., Hogberg H., Pamies D., 2021/07/25. International journal of molecular sciences, 22 (15) p. 7929. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_899FF5FD34ED]
 
Gene-Environment Interactions in Developmental Neurotoxicity: a Case Study of Synergy between Chlorpyrifos and CHD8 Knockout in Human BrainSpheres.
Modafferi S., Zhong X., Kleensang A., Murata Y., Fagiani F., Pamies D., Hogberg H.T., Calabrese V., Lachman H., Hartung T. et al., 2021/07. Environmental health perspectives, 129 (7) p. 77001. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EEF6B9982206]
 
Neuroinflammatory Response to TNFα and IL1β Cytokines Is Accompanied by an Increase in Glycolysis in Human Astrocytes In Vitro.
Pamies D., Sartori C., Schvartz D., González-Ruiz V., Pellerin L., Nunes C., Tavel D., Maillard V., Boccard J., Rudaz S. et al., 2021/04/14. International journal of molecular sciences, 22 (8). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5E8DC218E471]
 
Necrotizing enterocolitis induces T lymphocyte-mediated injury in the developing mammalian brain.
Zhou Q., Niño D.F., Yamaguchi Y., Wang S., Fulton W.B., Jia H., Lu P., Prindle T., Pamies D., Morris M. et al., 2021/01/06. Science translational medicine, 13 (575) pp. eaay6621. Peer-reviewed.
[DOI][Pmid][serval:BIB_034C3C918EC7]
2020
 
Organotypic Models to Study Human Glioblastoma: Studying the Beast in Its Ecosystem.
Pamies D., Zurich M.G., Hartung T., 2020/10/23. iScience, 23 (10) p. 101633. Peer-reviewed.
[DOI][Pmid][serval:BIB_3EDD5151369D]
 
Good Cell and Tissue Culture Practice 2.0 (GCCP 2.0) - Draft for stakeholder discussion and call for action.
Pamies D., Leist M., Coecke S., Bowe G., Allen D., Gstraunthaler G., Bal-Price A., Pistollato F., DeVries R., Hartung T. et al., 2020. ALTEX, 37 (3) pp. 490-492. Peer-reviewed.
[DOI][Pmid][serval:BIB_817AF164A7CA]
2019
Suitability of 3D human brain spheroid models to distinguish toxic effects of gold and poly-lactic acid nanoparticles to assess biocompatibility for brain drug delivery.
Leite PEC, Pereira M.R., Harris G., Pamies D., Dos Santos LMG, Granjeiro J.M., Hogberg H.T., Hartung T., Smirnova L., 2019/06/03. Particle and fibre toxicology, 16 (1) p. 22. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2A2AD5708646]
A Human iPSC-derived 3D platform using primary brain cancer cells to study drug development and personalized medicine.
Plummer S., Wallace S., Ball G., Lloyd R., Schiapparelli P., Quiñones-Hinojosa A., Hartung T., Pamies D., 2019/02/05. Scientific reports, 9 (1) p. 1407. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_968C606B3D56]
In vitro and in silico Models to Study Mosquito-Borne Flavivirus Neuropathogenesis, Prevention, and Treatment.
Chesnut M., Muñoz L.S., Harris G., Freeman D., Gama L., Pardo C.A., Pamies D., 2019. Frontiers in cellular and infection microbiology, 9 p. 223. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_ED849B658265]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University